These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7865883)

  • 1. Separation of v-Src-induced mitogenesis and morphological transformation by inhibition of AP-1.
    Frame MC; Simpson K; Fincham VJ; Crouch DH
    Mol Biol Cell; 1994 Nov; 5(11):1177-84. PubMed ID: 7865883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1.
    Catling AD; Wyke JA; Frame MC
    Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncoupling of the pathways which link MAP kinase to c-fos transcription and AP-1 in response to growth stimuli.
    Wyke AW; Lang A; Frame MC
    Cell Signal; 1996 Feb; 8(2):131-9. PubMed ID: 8730515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic action of AP-1 in v-Src-transformed cells.
    Wang L; Rodrigues NA; Wu Y; Maslikowski BM; Singh N; Lacroix S; Bédard PA
    J Virol; 2011 Jul; 85(13):6725-35. PubMed ID: 21507983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogenesis by v-Src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein.
    Wyke AW; Frame MC; Gillespie DA; Chudleigh A; Wyke JA
    Cell Growth Differ; 1995 Oct; 6(10):1225-34. PubMed ID: 8845299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1.
    Murakami M; Sonobe MH; Ui M; Kabuyama Y; Watanabe H; Wada T; Handa H; Iba H
    Oncogene; 1997 May; 14(20):2435-44. PubMed ID: 9188858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JunD/AP-1 Antagonizes the Induction of DAPK1 To Promote the Survival of v-Src-Transformed Cells.
    Maślikowski BM; Wang L; Wu Y; Fielding B; Bédard PA
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple signaling pathways control the activation of the CEF-4/9E3 cytokine gene by pp60v-src.
    Bojović B; Rodrigues N; Dehbi M; Bédard PA
    J Biol Chem; 1996 Sep; 271(37):22528-37. PubMed ID: 8798420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of AP-1 function in cellular transformation pathways.
    Suzuki T; Murakami M; Onai N; Fukuda E; Hashimoto Y; Sonobe MH; Kameda T; Ichinose M; Miki K; Iba H
    J Virol; 1994 Jun; 68(6):3527-35. PubMed ID: 8189491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The constitutive activation of the CEF-4/9E3 chemokine gene depends on C/EBPbeta in v-src transformed chicken embryo fibroblasts.
    Gagliardi M; Maynard S; Bojovic B; Bédard PA
    Oncogene; 2001 Apr; 20(18):2301-13. PubMed ID: 11402325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AP-1 factors play an important role in transformation induced by the v-rel oncogene.
    Kralova J; Liss AS; Bargmann W; Bose HR
    Mol Cell Biol; 1998 May; 18(5):2997-3009. PubMed ID: 9566919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of cellular transformation by glucocorticoid receptor mutants.
    Kameda T; Iba H
    Cancer Res; 1998 Mar; 58(5):867-70. PubMed ID: 9500440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation by the fos or jun oncogene does not increase AP-1 DNA-binding activity.
    Hawker KL; Pintzas A; Hennigan RF; Gillespie DA; Ozanne BW
    J Virol; 1993 Sep; 67(9):5487-95. PubMed ID: 8350408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
    Basso J; Briggs J; Findlay C; Bos T
    Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular targeting of pp60src expression: localization of v-src to adhesion plaques is sufficient to transform chicken embryo fibroblasts.
    Liebl EC; Martin GS
    Oncogene; 1992 Dec; 7(12):2417-28. PubMed ID: 1334249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogenesis induced by pp60v-src is not accompanied by increased expression of immediate early response genes.
    Welham MJ; Wyke JA; Lang A; Wyke AW
    Oncogene; 1990 Feb; 5(2):161-9. PubMed ID: 2108404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
    Leupold JH; Asangani I; Maurer GD; Lengyel E; Post S; Allgayer H
    Mol Cancer Res; 2007 May; 5(5):485-96. PubMed ID: 17510314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
    Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
    Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.